Collected in [mm/yy] and may change.
This percentage may not represent 100% of formulary lives due to data limitations
The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This information is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this information, the information may not be as current or comprehensive when you view it. Please contact the plan for more information about coverage or any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change.
This information is not a promise of coverage or payment. It is not intended to give reimbursement advice or increase reimbursement by any payer. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, reimbursement policies, restrictions, or requirements that may apply.
*"Majority" means that ≥51% of covered lives have coverage for INVOKANA®
*"Majority" means that ≥51% of lives are covered.+Prior Authorization (PA) and/or Step Therapy (ST):This plan requires the physician to gain prior approval for use of this product, and/or requires the patient to step through and fail an alternate product before this product is dispensed.
Please see below for details regarding references.
These percentages may not represent 100% of formulary lives due to data limitations.
